We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Oncology

Open Access Journals

Looking to publish your next article?

Each journal in this portfolio is PubMed indexed, peer-reviewed and fully open access; aiming to serve the academic research community, scientific community and practitioner community.

The below journals have various specialties in:

  • tumor immunology
  • immunological biomarkers
  • anticancer therapies
  • thermal energy-based disease treatment
  • antibody research and development
  • blood and lymphatic cancer
  • use of preventative and integrated cancer treatment interventions
  • molecular diagnosis, targeted molecular or precision therapy for all types of cancer
  • hepatobiliary tumors
  • application of oncolytic viruses for the treatment of cancer

Explore the links below to discover our range of open access journals and find the perfect home for your research.

Publishing Open Access

Taylor & Francis offers publishing options that support the needs of authors and researchers worldwide. To learn more about open access publishing, click the link below.
GO TO PUBLISHING OPTIONS

OncoImmunology

An open access journal | 2019 Impact Factor 5.869

OncoImmunology focuses specifically on tumor immunology. As a result of recent progress in the field, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies.

There is a need for research that explores the combination of conventional anticancer therapies with immunotherapies. OncoImmunology accepts high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are welcome.

GO TO ONCOIMMUNOLOGY

International Journal of Hyperthermia

An open access journal | 2019 Impact Factor 3.574

The International Journal of Hyperthermia provides a forum for the publication of research, perspectives and letters relating to the science, engineering, physics and clinical application of thermal energy-based disease treatment.

Submitted manuscripts will be considered for publication in one of the following categories:

  • Clinical Studies: Disease treatment in clinical settings, including clinical trials and case studies that involve either human or animal patients
  • Biological Studies: Biological, biochemical, anatomical or physiological studies of a basic or pre-clinical nature using basic biochemical, cell, animal, or computational models
  • Physics and Engineering: Development of technologies and strategies for energy delivery and control, with an end goal to effect specific biologic responses leading to therapeutic outcomes

GO TO INTERNATIONAL JOURNAL OF HYPERTHERMIA

mAbs

An open access journal | 2019 Impact Factor 4.634

A multi-disciplinary journal dedicated to the art and science of antibody research and development. mAbs has a strong scientific and medical focus, which strives to serve a broader readership of scientists, clinical researchers, and physicians, as well as the wider mAb community, including our readers involved in technology transfer, legal issues, investment, strategic planning and the regulation of therapeutics.

mAbs publishes relevant and timely original research, as well as authoritative overviews, commentary and perspectives providing context for the work presented in mAbs and for key results published elsewhere.

GO TO MABS

Blood and Lymphatic Cancer: Targets and Therapy

A Dove Medical Press journal, part of Taylor & Francis Group

Blood and Lymphatic Cancer: Targets and Therapy focuses on blood and lymphatic cancer research, the identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.

GO TO BLOOD AND LYMPHATIC CANCER

Cancer Management and Research

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 2.886

Cancer Management and Research is an open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.

GO TO CANCER MANAGEMENT AND RESEARCH

OncoTargets and Therapy

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 3.337

OncoTargets and Therapy focuses on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.

GO TO ONCOTARGETS AND THERAPY

Journal of Hepatocellular Carcinoma

A Dove Medical Press journal, part of Taylor & Francis Group | 2019 Impact Factor 4.655

The Journal of Hepatocellular Carcinoma offers the international community a platform for the dissemination and study of clinical, translational and basic research findings in this rapidly developing field.

Exciting developments in the areas of epidemiology, vaccination, hepatitis therapy, pathology, molecular tumor classification and prognostication, new radiological techniques, amazing new classes of targeted medical therapies and a resultant vast increase in the associated clinical trials and reports are all a vital part of focusing on hepatobiliary tumors.

GO TO HEPATOCELLULAR CARCINOMA

Oncolytic Virotherapy

A Dove Medical Press journal, part of Taylor & Francis Group

Oncolytic Virotherapy publishes original research, study protocols, reviews, editorials and commentaries on all aspects of oncolytic virology, namely the application of oncolytic viruses for the treatment of cancer.

GO TO ONCOLYTIC VIROTHERAPY

Dove Medical Press Author Program

Learn how you can receive fast-track processing of papers, the rapid delivery of a PDF of your paper and a 10% discount on the article publishing charge.
LEARN MORE

Cogent Medicine

Cogent Medicine, part of Taylor & Francis Group, publishes experimental, translational and clinical approaches across all areas of biomedical sciences, clinical research and practice.
GO TO COGENT MEDICINE

F1000Research

An open research publishing platform offering rapid publication of articles and other research outputs. All articles benefit from transparent peer-review and the inclusion of all source data.
GO TO F1000RESEARCH